Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada.
Int J Nanomedicine. 2011;6:321-30. doi: 10.2147/IJN.S16749. Epub 2011 Feb 10.
The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from -55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed.
本工作旨在研究纳米晶纤维素 (NCC) 作为药物传递赋形剂的用途。通过酸水解法制备的 NCC 晶须具有纳米级尺寸,表现出高度的结晶度。这些晶须结合了大量的水溶性、可离子化药物四环素和阿霉素,在 1 天内迅速释放。十六烷基三甲基溴化铵 (CTAB) 结合到 NCC 的表面,并以浓度依赖的方式使 Zeta 电位从 -55mV 增加至 0mV。具有 CTAB 修饰表面的 NCC 晶须结合了大量疏水性抗癌药物多西紫杉醇、紫杉醇和依托泊苷。这些药物在 2 天内以受控方式释放。发现 NCC-CTAB 复合物能够结合 KU-7 细胞,并观察到细胞摄取的证据。